Bavarian Nordic upgrades guidance for third time in three weeks

For the third time in three weeks, Bavarian Nordic has increased its stated financial expectations for the year. This comes after a deal was secured with the US government concerning the firm’s monkeypox vaccine.
by christopher due karlsson, translated by catherine brett

Bavarian Nordic has entered into an agreement with the US government concerning the firm’s monkeypox vaccine, and in connection with this, has upgraded its financial guidance again.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
  • Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
    Must contain at least 2 characters
    Must contain at least 2 characters

    Get full access for you and your coworkers

    Start a free company trial today

    Share article

    Sign up for our newsletter

    Stay ahead of development by receiving our newsletter on the latest sector knowledge.

    Newsletter terms

    Front page now

    Further reading